Members

Neon Therapeutics



Member Type: Emerging Biotech/Pharmaceutical Companies

Neon Therapeutics is an immuno-oncology company focused on developing novel therapeutics leveraging neoantigen biology to treat cancer. A neoantigen-based product engine will allow Neon to develop further treatment modalities including next-generation vaccines and T cell therapies targeting both personalized as well as shared neoantigens. Neon Therapeutics’ lead program is a personalized neoantigen vaccine that builds upon years of research and development at the Broad Institute and Dana-Farber Cancer Institute, and is already in multiple clinical trials.

http://neontherapeutics.com

Join Today

Contact Mary Bordoni, Director, Membership & Development, for information about joining the Coalition.




Download a Member List